Domestic pharmaceutical firms rush to launch off-patent drugs

Korea's local pharmaceutical makers are scrambling to introduce a wider variety of first generic products with bigger market potentiality this year in a to have a strong foothold in the domestic ethical market.

The patent- and postmarketing surveillance-related periods of more than four substances, which belong to such therapeutic fields as anti-allergic, antibiotic/antimicrobial, di...